Business

Conavi Medical to Showcase FDA-Cleared Hybrid Imaging System at TCT 2026

Financial Post · October 15, 2026 at 7:54 a.m.

This will be Conavi’s first TCT conference since receiving U.S.

Food and Drug Administration (FDA) 510(k) clearance for its next-generation hybrid intravascular ultrasound (IVUS) and optical coherence tomography (OCT) imaging system.

Conavi will showcase the cleared system alongside an expanded scientific and educational program featuring a podium case presentation, a new preclinical abstract and participation in two CRF Imaging Lab sessions.

Read the full article on Financial Post ›

5News aggregated this summary from the outlet’s public feed. The full article, with all the context, is on financialpost.com — the content belongs to Financial Post.

Conavi Medical to Showcase FDA-Cleared Hybrid Imaging System at TCT 2026

More from Financial Post

Axi Launches MCP Integration Connecting MT5 Accounts to Claude

Smarsh Taps Former ACI Worldwide Executive Alessandro Silva as Chief Growth Officer to Drive Next Phase of Global Expansion

Beren Therapeutics Presents New Adrabetadex Data Showing Preservation of Neurological Function for More Than 10 Years in Children with Infantile-Onset NPC

TreviPay Named a Leader in Two 2026 IDC MarketScape Assessments for AI-Enabled A/R Automation and Embedded Payments

More in Business

Axi Launches MCP Integration Connecting MT5 Accounts to Claude

Smarsh Taps Former ACI Worldwide Executive Alessandro Silva as Chief Growth Officer to Drive Next Phase of Global Expansion

Beren Therapeutics Presents New Adrabetadex Data Showing Preservation of Neurological Function for More Than 10 Years in Children with Infantile-Onset NPC

TreviPay Named a Leader in Two 2026 IDC MarketScape Assessments for AI-Enabled A/R Automation and Embedded Payments

Visa Direct Launches Stablecoin-Powered Money Movement as Pilots Move to Production

Canadian lender Cash Today under scrutiny as 44,000 loans vanish